Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
20074.4k citationsJohn G. Bartlett, Thomas M. File et al.Clinical Infectious Diseasesprofile →
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
20162.3k citationsAndré C. Kalil, Mark L. Metersky et al.Clinical Infectious Diseasesprofile →
19922.2k citationsSherwood L. Gorbach, John G. Bartlett et al.profile →
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
20001.8k citationsJohn G. Bartlett, Thomas M. File et al.Clinical Infectious Diseasesprofile →
Botulinum Toxin as a Biological Weapon
20011.3k citationsRobert Schechter, Thomas V. Inglesby et al.JAMAprofile →
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
20071.3k citationsJohn G. Bartlett et al.Clinical Infectious Diseasesprofile →
Smallpox as a Biological Weapon
19991.2k citationsThomas V. Inglesby, John G. Bartlett et al.JAMAprofile →
Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia
19781.0k citationsJohn G. Bartlett, Sherwood L. Gorbach et al.profile →
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
20091.0k citationsSherwood L. Gorbach, John G. Bartlett et al.Clinical Infectious Diseasesprofile →
Tularemia as a Biological Weapon
20011.0k citationsThomas V. Inglesby, John G. Bartlett et al.JAMAprofile →
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006846 citationsJohn G. Bartlett et al.Clinical Infectious Diseasesprofile →
Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes
2004560 citationsTrish M. Perl, John G. Bartlett et al.Clinical Infectious Diseasesprofile →
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2010398 citationsSherwood L. Gorbach, John G. Bartlett et al.profile →
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis
1978387 citationsJohn G. Bartlett, N Moon et al.profile →
Anaerobic Infections
1974350 citationsSherwood L. Gorbach, John G. Bartlettprofile →
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
1977343 citationsJohn G. Bartlett, Andrew B. Onderdonk et al.profile →
A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture.
1979319 citationsJohn G. Bartlett et al.PubMedprofile →
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016289 citationsAndré C. Kalil, Mark L. Metersky et al.Clinical Infectious Diseasesprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by John G. Bartlett
Since
Specialization
Citations
This map shows the geographic impact of John G. Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Bartlett more than expected).
Fields of papers citing papers by John G. Bartlett
This network shows the impact of papers produced by John G. Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Bartlett. The network helps show where John G. Bartlett may publish in the future.
Co-authorship network of co-authors of John G. Bartlett
This figure shows the co-authorship network connecting the top 25 collaborators of John G. Bartlett.
A scholar is included among the top collaborators of John G. Bartlett based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with John G. Bartlett. John G. Bartlett is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Kalil, André C., Mark L. Metersky, Michael Klompas, et al.. (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases. 63(5). e61–e111.2347 indexed citations breakdown →
2.
Bartlett, John G.. (2005). FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection.. PubMed. 17(3). 15–15.1 indexed citations
3.
Bartlett, John G.. (2004). Methicillin-resistant staphylococcus aureus infections in correctional facilities-Georgia, California, and Texas, 2001-2003. Infectious Diseases in Clinical Practice. 12(3). 202–203.214 indexed citations
4.
Bartlett, John G.. (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. Infectious Diseases in Clinical Practice. 12(4). 265–266.78 indexed citations
5.
Bartlett, John G.. (2004). Strain-specific immune response to haemophilus influenzae in chronic obstructive pulmonary disease. Infectious Diseases in Clinical Practice. 12(4). 266–267.11 indexed citations
6.
Bartlett, John G.. (2004). Virology: SARS virus infection of cats and ferrets. Infectious Diseases in Clinical Practice. 12(3).17 indexed citations
7.
Bartlett, John G.. (2004). Progress toward global eradication of dracunculiasis, January-June 2003. Infectious Diseases in Clinical Practice. 12(3).1 indexed citations
8.
Bartlett, John G.. (2004). Neutralization of staphylococcus aureus panton valentine leukocidin by intravenous immunoglobulin in vitro. Infectious Diseases in Clinical Practice. 12(4). 262–263.5 indexed citations
9.
Bartlett, John G.. (2004). An outbreak of escherichia coli 0157 infection following exposure to a contaminated building. Infectious Diseases in Clinical Practice. 12(3).3 indexed citations
10.
Bartlett, John G.. (2004). Resistance in Anaerobic Bacteria: Worrisome Developments. Infectious Diseases in Clinical Practice. 12(6). 380–381.1 indexed citations
11.
Bartlett, John G.. (2004). Influenza burden of illness: Estimates from a national prospective survey of household contacts in France. Infectious Diseases in Clinical Practice. 12(3).4 indexed citations
12.
Arnon, Stephen S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum toxin as a biological weapon. JAMA. 285(8).95 indexed citations
13.
Bartlett, John G., et al.. (2000). Public health service task force updates recommendations for use of antiretroviral drugs in pregnant women.. PubMed. 12(3). 8–9, 11.1 indexed citations
14.
File, Thomas M., John G. Bartlett, Gail H. Cassell, et al.. (1997). THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN. Infectious Diseases in Clinical Practice. 6(Supplement 2). S28–S31.8 indexed citations
15.
Bartlett, John G.. (1996). Assessment of response to antimicrobial therapy and time to discharge in patients hospitalized with community-acquired pneumonia. Infectious Diseases in Clinical Practice. 5.4 indexed citations
16.
Bartlett, John G.. (1995). Community-acquired pneumonia: Current status. Infectious Diseases in Clinical Practice. 4.2 indexed citations
17.
Bartlett, John G.. (1982). Therapeutic trial of moxalactam in intra-abdominal sepsis and gynaecological infections. 8(5). 483–486.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.